CardioRisk Calculator vs iCCS

CardioRisk Calculator™ simplifies cardiovascular risk stratification and is a Canadian dyslipidemia guidelines application. CardioRisk Calculator™ provides: -quick calculations on % LDL-C reductions -concise drug dosage information -clear snapshot of a patient's CV risk -options to bring lipid levels to target -easy identification of familial hypercholesterolemia This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia. Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order): - Amgen Canada - Bayer Inc - Boehringer Ingelheim (Canada) Ltd - FH Canada - HLS Therapeutics - Janssen Inc - Novo Nordisk Canada - Sanofi Canada

The iCCS app provides users with top CCS Guidelines. Read and use CCS Guidelines in practice, for teaching, and self-guided learning. Click on a topic in the app to view the table of contents, then navigate by chapter and section. iCCS includes Guidelines on: - Fitness to Drive (2023) - Peripheral Arterial Disease (2022)  - Cardiorenal Risk Reduction (2022)  - Heart Failure (2017, 2020, 2021)  - Dyslipidemia (2021)  - Atrial Fibrillation (2020)  Visit www.ccs.ca/guidelines for many more Guidelines, Clinical Practice Updates, clinical decision support tools and resources including infographics, educational webinars, slide sets and pocket guides.